Partnering

Zenobia is actively seeking partners for its internal drug discovery (pipeline) programs.

Zenobia partners and collaborates with a broad range of companies including early stage, medium and large biotechnology and pharmaceutical companies. In some cases, our partner proposes a target and we take it forward collaboratively through our discovery services or we may choose to take forward an existing Zenobia program.

Although the focus of Zenobia is CNS disease, we have partnered in all therapeutic areas which can benefit from our fragment-based lead discovery and structural biology approach.  Our partnerships are focused on fragment-based lead discovery and new, novel screening methods.

Some of our collaborators are listed on the right.  Discovery service partners are not listed and prefer to remain anonymous.